Cue Biopharma (CUE) Financials

$31.64

$1.09 (3.57%)

As on 15-Sep-2026 16:00EDT

Market cap

$209 Mln

Revenue (TTM)

$38 Mln

P/E Ratio

--

P/B Ratio

90.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	37.65	27.47	9.29	5.49	1.25	14.94
Cost of Revenue	3.40	3.48	2.35	38.10	1.81	-1.78
Gross Profit	37.54	27.47	9.29	-32.61	1.25	14.94
Operating Expenses	136.22	53.99	50.79	19.54	54.47	58.65
Operating Profit (EBIT)	-98.64	-26.52	-41.50	-52.15	-53.23	-43.71
Other Income	--	--	--	--	--	--
Profit before Tax	-163.61	-26.10	-40.67	-50.73	-53.01	-43.67
Provision for Tax	0.50	0.50	-40.67	3.27	-0.21	0.50
Profit after Tax (Net Income)	-164.11	-26.60	-40.67	-50.73	-53.01	-44.16
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-53.01	-44.16

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	2.31	26.43	17.50	37.09	65.68	65.49
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.18	2.29	1.00	7.36	14.05	5.12
Current Liabilities	21.22	13.49	13.69	17.08	11.55	12.79
Total Liabilities	51.93	42.21	32.19	61.53	91.28	83.40

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.08	5.23	7.05	10.08	14.10	14.93
Current Assets	26.62	36.98	25.14	51.45	77.19	68.47
Total Assets	51.93	42.21	32.19	61.53	91.28	83.40
Total Debt*	8.81	4.20	8.88	14.70	19.32	12.02
Net Current Assets	5.41	23.49	11.45	34.37	65.64	55.68

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-21.69	-36.33	-39.96	-41.81	-38.84
Cash Flow from Investing Activities	--	0.08	0.03	25.00	-24.61	9.11
Cash from Financing Activities	--	26.29	10.24	11.86	53.66	19.23
Net Cash Inflow / Outflow	--	--	--	--	-12.76	-10.50

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-27.00	-7.22	-16.44	-32.28	-40.60	-42.04
Cash EPS ($)	--	-6.28	-15.49	-30.10	-39.22	-43.73
Adjusted Book Value ($)	--	7.18	7.07	23.60	50.30	62.34
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.89	-14.68	-25.43	-32.02	-36.97
Free Cash Flow per Share ($)	--	-5.94	-14.71	-25.43	-32.15	-37.84

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-93.33	-104.09	-74.18	-65.24	-54.00
ROE (%)	-1,141.94	-121.11	-149.03	-98.73	-80.82	-61.16
ROA (%)	-293.35	-71.51	-86.80	-66.40	-60.69	-48.28
EBIT Margin (%)	-260.64	-93.73	-429.40	-901.42	-4,200.56	-292.56
Net Margin (%)	-435.83	-96.85	-437.97	-924.10	-4,257.83	-295.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	354.37	1.96	0.69	3.41	-0.92	3.74
EBIT Growth (%)	-155.70	35.44	19.42	5.37	-19.64	2.95
Net Profit Growth (%)	-321.93	34.60	19.83	4.30	-20.04	1.39
EPS Growth (%)	-63.39	0.56	0.49	0.20	0.03	0.07
Book Value Growth (%)	-93.62	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.04	-0.07	-0.08	-0.07	-0.27
Price / Book Value	90.63	0.04	0.15	0.11	0.06	0.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.76	0.98	0.31	0.64	1.05	0.89
Close Price ($)	31.56	9.16	32.70	79.20	85.50	339.30
High Price ($)	41.42	52.50	96.00	153.60	382.20	552.60
Low Price ($)	4.97	6.91	13.50	51.00	65.40	289.56
Market Cap ($ Cr)	208.78	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.16	0.51	0.40	0.29	0.18
Short term debt to equity ratio	0.70	0.07	0.45	0.20	0.08	0.11
Current Ratio	1.25	2.74	1.84	3.01	6.68	5.35
Quick Ratio	1.25	--	--	3.01	6.68	5.35
Interest Coverage	-1,210.91	-72.11	-50.10	-39.75	-73.26	-25.24

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.32	27.11	10.18	30.93	4.58	21.03
Asset Turnover	0.67	0.74	0.20	0.07	0.01	0.16
Receivable days	--	55.79	51.97	58.38	469.33	55.74
Inventory Days	--	--	0.00	0.00	0.00	0.00
Payable days	--	355.33	491.46	29.87	538.12	-478.75
Cash Conversion Cycle	--	--	-439.48	28.51	-68.79	534.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.